Ledger.Open graph →
SEC Form D · filed April 7, 2023

Acta Pharmaceuticals, Inc

Offering
$10.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

George Alex · Boston, MAExec · Director · PromoterRudolph Tanzi · Boston, MAExec · Director · PromoterJane E. Ingalls · Denver, COExec · Director · PromoterJohn Ackerley · Grand Cayman, Cayman IslandsExec · Director · PromoterChristian Carnes · Dover, DEExec · Director · PromoterJack Sunier · Dover, DEExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗